CNTX
Income statement / Annual
Last year (2023), Context Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Context Therapeutics Inc.'s net income was -$23.96 M.
See Context Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$12,044.00 |
$9,268.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$12,044.00 |
-$9,268.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$17.78 M
|
$7.09 M
|
$3.81 M
|
$1.64 M
|
$2.41 M
|
| General & Administrative
Expenses |
$7.29 M
|
$7.79 M
|
$3.63 M
|
$930,667.00
|
$2.97 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.29 M
|
$7.79 M
|
$3.63 M
|
$930,667.00
|
$2.97 M
|
| Other Expenses |
$0.00 |
-$2,004.00 |
$123,872.00 |
$9.88 M |
$93,365.00 |
| Operating Expenses |
$25.07 M |
$14.88 M |
$7.44 M |
$2.57 M |
$5.38 M |
| Cost And Expenses |
$25.07 M |
$14.88 M |
$7.44 M |
$2.57 M |
$5.38 M |
| Interest Income |
$1.16 M |
$547,268.00 |
$64.24 |
$661.22 |
$1,100.39 |
| Interest Expense |
$0.00 |
$547,268.00 |
$64,240.00 |
$661,224.00 |
$1.10 M |
| Depreciation &
Amortization |
$12,044.00
|
$9,268.00
|
-$3.09 M
|
$2.57 M
|
$5.38 M
|
| EBITDA |
-$25.06 M
|
-$14.83 M
|
-$10.53 M
|
$0.00
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.11 M
|
$545,264.00
|
$68,949.00
|
$9.22 M
|
-$1.01 M
|
| Income Before Tax |
-$23.96 M |
-$14.84 M |
-$10.46 M |
$6.64 M |
-$6.38 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$545,264.00 |
-$3.02 M |
$661,224.00 |
$1.10 M |
| Net Income |
-$23.96 M |
-$14.29 M |
-$7.43 M |
$6.64 M |
-$7.48 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.5 |
-0.9 |
-0.47 |
0.61 |
-0.68 |
| EPS Diluted |
-1.5 |
-0.9 |
-0.47 |
0.61 |
-0.68 |
| Weighted Average Shares
Out |
$15.97 M
|
$15.97 M
|
$15.97 M
|
$10.96 M
|
$10.96 M
|
| Weighted Average Shares
Out Diluted |
$15.97 M
|
$15.97 M
|
$15.97 M
|
$10.96 M
|
$10.96 M
|
| Link |
|
|
|
|
|
